Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Network-based analysis identifies epigenetic biomarkers of esophageal squamous cell carcinoma progression.

Cheng CP, Kuo IY, Alakus H, Frazer KA, Harismendy O, Wang YC, Tseng VS.

Bioinformatics. 2014 Nov 1;30(21):3054-61. doi: 10.1093/bioinformatics/btu433. Epub 2014 Jul 10.

2.

Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.

Kuo IY, Chang JM, Jiang SS, Chen CH, Chang IS, Sheu BS, Lu PJ, Chang WL, Lai WW, Wang YC.

Int J Med Sci. 2014 May 30;11(8):779-87. doi: 10.7150/ijms.7405. eCollection 2014.

3.

Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers.

Lima SC, Hernández-Vargas H, Simão T, Durand G, Kruel CD, Le Calvez-Kelm F, Ribeiro Pinto LF, Herceg Z.

Epigenetics. 2011 Oct 1;6(10):1217-27. doi: 10.4161/epi.6.10.17199. Epub 2011 Oct 1.

PMID:
21946330
4.

Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis.

Li X, Zhou F, Jiang C, Wang Y, Lu Y, Yang F, Wang N, Yang H, Zheng Y, Zhang J.

PLoS One. 2014 Jul 22;9(7):e103162. doi: 10.1371/journal.pone.0103162. eCollection 2014.

5.

Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.

Hibino S, Kanda M, Oya H, Takami H, Shimizu D, Nomoto S, Hishida M, Niwa Y, Koike M, Yamada S, Nishikawa Y, Asai M, Nakayama G, Fujii T, Sugimoto H, Fujiwara M, Kodera Y.

Oncol Rep. 2014 Feb;31(2):693-700. doi: 10.3892/or.2013.2901. Epub 2013 Dec 5.

PMID:
24317529
6.

Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma.

Li JS, Ying JM, Wang XW, Wang ZH, Tao Q, Li LL.

Chin J Cancer. 2013 Jan;32(1):3-11. doi: 10.5732/cjc.011.10381. Epub 2012 May 8. Review.

7.
8.

LMP gene promoter hypermethylation is a mechanism for its down regulation in Kazak's esophageal squamous cell carcinomas.

Zheng F, Hasim A, Anwer J, Niyaz M, Sheyhidin I.

Mol Biol Rep. 2013 Mar;40(3):2069-75. doi: 10.1007/s11033-012-2138-2. Epub 2013 Jan 3.

PMID:
23283737
9.

Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.

He Y, Wang Y, Li P, Zhu S, Wang J, Zhang S.

Dig Dis Sci. 2011 Mar;56(3):681-8. doi: 10.1007/s10620-010-1369-0. Epub 2010 Aug 20.

PMID:
20725785
10.

Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.

Tanaka K, Imoto I, Inoue J, Kozaki K, Tsuda H, Shimada Y, Aiko S, Yoshizumi Y, Iwai T, Kawano T, Inazawa J.

Oncogene. 2007 Sep 27;26(44):6456-68. Epub 2007 Apr 16.

PMID:
17438526
11.
12.

Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.

Hoshimoto S, Takeuchi H, Ono S, Sim MS, Huynh JL, Huang SK, Marzese DM, Kitagawa Y, Hoon DS.

J Thorac Oncol. 2015 Mar;10(3):509-17. doi: 10.1097/JTO.0000000000000441.

13.

Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma.

Zhao BJ, Tan SN, Cui Y, Sun DG, Ma X.

Dis Esophagus. 2008;21(7):582-8. doi: 10.1111/j.1442-2050.2007.00808.x.

PMID:
19040536
14.

PTEN hypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma.

Pan QF, Li WT, Dong HC, Chen YZ, Yin L, Liu W, Wang WW, Liu D, Li SG, Gu WY, Chen JZ, Yang L, Zhang WJ, Li F.

Dis Esophagus. 2014 May-Jun;27(4):396-402. doi: 10.1111/dote.12106. Epub 2013 Aug 27.

PMID:
23980519
15.

Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.

Zhao BJ, Sun DG, Zhang M, Tan SN, Ma X.

Dis Esophagus. 2009;22(1):55-61. doi: 10.1111/j.1442-2050.2008.00848.x. Epub 2008 Jun 17.

PMID:
18564167
16.

Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma.

Cui X, Zhao Z, Liu D, Guo T, Li S, Hu J, Liu C, Yang L, Cao Y, Jiang J, Liang W, Liu W, Li S, Wang L, Wang L, Gu W, Wu C, Chen Y, Li F.

J Exp Clin Cancer Res. 2014 Feb 17;33:20. doi: 10.1186/1756-9966-33-20.

17.

DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas.

Nie Y, Yang G, Song Y, Zhao X, So C, Liao J, Wang LD, Yang CS.

Carcinogenesis. 2001 Oct;22(10):1615-23.

18.

DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.

Liu R, Gu J, Jiang P, Zheng Y, Liu X, Jiang X, Huang E, Xiong S, Xu F, Liu G, Ge D, Chu Y.

Clin Cancer Res. 2015 Feb 15;21(4):854-63. doi: 10.1158/1078-0432.CCR-14-1740. Epub 2014 Dec 15.

19.

Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma.

Yue D, Fan Q, Chen X, Li F, Wang L, Huang L, Dong W, Chen X, Zhang Z, Liu J, Wang F, Wang M, Zhang B, Zhang Y.

Exp Cell Res. 2014 Mar 10;322(1):149-58. doi: 10.1016/j.yexcr.2013.11.009. Epub 2013 Nov 21.

PMID:
24269829
20.
Items per page

Supplemental Content

Write to the Help Desk